title: Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
authors.forename: Michiko
authors.initials: M
authors.lastname: Yamagata
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Murohisa
authors.forename: Kohei
authors.initials: K
authors.lastname: Tsuchida
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Okamoto
authors.forename: Saburo
authors.initials: S
authors.lastname: Tsunoda
authors.forename: Masae
authors.initials: M
authors.lastname: Nakamura
authors.forename: Koji
authors.initials: K
authors.lastname: Kusano
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Majima
authors.forename: Toru
authors.initials: T
authors.lastname: Kuniyoshi
authors.forename: Makoto
authors.initials: M
authors.lastname: Iijima
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Sugaya
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Hiraishi
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004279:DNA, Viral / Q000097:blood / Q000235:genetics*; D004317:Doxorubicin / Q000627:therapeutic use; D006509:Hepatitis B / Q000097:blood / Q000209:etiology* / Q000235:genetics; D006515:Hepatitis B virus / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D016393:Lymphoma, B-Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D004279:DNA, Viral; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone